Technical Articles
MHC class II tetramer technology for tumors
MHC class II tetramer technology: a new key to cracking tumor immune escape
One of the main strategies for tumor cells to evade T cell recognition is to downregulate MHC molecule expression. When MHC molecules are deficient, tumor cells no longer present mutant antigens, causing T cells to lose their tracking and attacking targets, thus allowing them to proliferate "invisibly". This mechanism is particularly common in solid tumors, posing a huge challenge to immunotherapy
View details
- Cancer
- MHC class II tetramer technology for tumors
- immunology
- 1











